Medical News

RSS

African-American women are having fewer children and breastfeeding less

Keck School of Medicine researchers report that African-American women are having fewer children and breastfeeding less, which might translate to escalating rates of breast cancer in the African-American community.

3 Aug 2004

Clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease

The four-year clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease, a degenerative disorder of the central nervous system.

3 Aug 2004

Basketball and cycling rank highest in U.S. recreational injuries

Basketball, cycling, football and soccer will be on the minds of millions of Americans as they watch the Summer Olympic games, but Loyola University Health System’s Dr. Pietro Tonino is cautioning the public that these sports are the ones that have the most injuries.

3 Aug 2004

Entirely new approach to the treatment of aging

Dispelling the belief that the only way to treat such conditions is by fixing or replacing damaged genes, they instead focused on the field of epigenetics—the study of changes in gene silencing that occur without changes in the genes themselves.

3 Aug 2004

The NHS is effectively being privatised

The NHS is effectively being privatised – broken up into hundreds of competing companies with an independent regulator overseeing the system according to Professor Allyson Pollock of UCL's School of Public Policy.

3 Aug 2004

$19 million in grants to help 66 of the nation’s health centers expand capacity

The Department of Health and Human Services has announced more than $19 million in grants to help 66 of the nation’s health centers expand capacity to serve 270,000 more rural and inner-city Americans, including many without health insurance.

3 Aug 2004

Third of heart failure patients face increased risk of death because they do not receive an angiotensin-converting enzyme (ACE) inhibitor

Overwhelming evidence accumulated during almost 20 years of clinical experience has established the benefits of this drug, which blocks the harmful effects of angiotensin, a substance that causes blood vessels to narrow, said the study authors.

3 Aug 2004

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

CV Therapeutics has announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a restricted patient population.

3 Aug 2004

FDA approval for mint flavor nicotine gum

Watson Pharmaceuticals announced today that it has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for nicotine polacrilex gum, mint flavor, in the 2 and 4 mg strengths.

3 Aug 2004

Aventis ships its influenza vaccine, Fluzone

Aventis began to ship its influenza vaccine (Fluzone(R), Influenza Virus Vaccine) today, meeting the company's goal to provide Fluzone vaccine to customers to allow health-care providers to plan successful immunization programs for the upcoming influenza season.

3 Aug 2004

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).

3 Aug 2004

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics has announced the initiation of a multi-center, multi- national Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate in chronic hepatitis B (HBV) infected patients.

3 Aug 2004

Free prostate screening days for men in the Washington DC area

The Lombardi Comprehensive Cancer Center and the Department of Urology at Georgetown University Hospital are offering their tenth annual free prostate screening days for local area men.

3 Aug 2004

New Drug Application with the U.S. Food and Drug Administration for Tarceva

OSI Pharmaceuticals and Genentech have announced that OSI completed the submission of a New Drug Application with the U.S. Food and Drug Administration for Tarceva (erlotinib HCl),

3 Aug 2004

New screening technique to look for genes that change patients' responses to cancer drugs and other medications

Scientists have developed a new screening technique to help them look for genes that change patients' responses to cancer drugs and other medications.

3 Aug 2004

10 Best Cities for African Americans to live, work, and play

This month, in its July 2004 issue, Black Enterprise magazine released the 10 Best Cities for African Americans to live, work, and play. There is a striking resemblance between the 2004 listing and the 2001 ranking. Readers once again selected Washington, DC, as the second best city for African Americans.

3 Aug 2004

British Government’s failure to publish the long-promised TB Action Plan

Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government’s failure to publish the long-promised TB Action Plan.

3 Aug 2004

International study into children in care

The 14-month study will examine policy and systems in comparable countries including the UK, USA, New Zealand and Sweden. The aim is to improve the lot of children in care around the world.

3 Aug 2004

Pregnant women in India may be volunteering for HIV research without fully understanding the benefits or consequences

Pregnant women may be volunteering to participate in HIV research without fully understanding the benefits or consequences, according to a study published today in BMC Medicine.

3 Aug 2004

Recommendation against the use of chemotherapy sensitivity and resistance assays

A new technology assessment from the American Society of Clinical Oncology states that the use of chemotherapy sensitivity and resistance assays (CSRAs) to select chemotherapeutic agents for cancer patients should not be undertaken outside of the clinical trial setting.

3 Aug 2004

Medical News

African-American women are having fewer children and breastfeeding less

Clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease

Basketball and cycling rank highest in U.S. recreational injuries

Entirely new approach to the treatment of aging

The NHS is effectively being privatised

$19 million in grants to help 66 of the nation’s health centers expand capacity

Third of heart failure patients face increased risk of death because they do not receive an angiotensin-converting enzyme (ACE) inhibitor

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

FDA approval for mint flavor nicotine gum

Aventis ships its influenza vaccine, Fluzone

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Free prostate screening days for men in the Washington DC area

New Drug Application with the U.S. Food and Drug Administration for Tarceva

New screening technique to look for genes that change patients' responses to cancer drugs and other medications

10 Best Cities for African Americans to live, work, and play

British Government’s failure to publish the long-promised TB Action Plan

International study into children in care

Pregnant women in India may be volunteering for HIV research without fully understanding the benefits or consequences

Recommendation against the use of chemotherapy sensitivity and resistance assays

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News